-
Sector Analysis
New![]()
Automotive Electrified Vehicles Market Trends and Analysis by Technology, Companies and Forecast to 2028
Automotive Electrified Vehicles Market Report Overview The automotive electrified Vehicles market size is estimated at 26.5 million units in 2023. The market is expected to register a CAGR of more than 15% during 2023-2028. The market growth will be supported by the volatile gasoline prices that is propelling the demand for EVs. The new movement towards the electrification of transportation has been influenced by macroeconomic, political, and environmental developments like oil dependence, increased competition, and rising carbon emissions. Automotive Electrified...
-
Thematic Analysis
New![]()
Component Makers Sector Scorecard, Q3 2023 Update – Thematic Intelligence
Component makers will continue to face challenging times in the rest of 2023 as global economies struggle to cope with the fallout from the US-China trade war and the disappointing Chinese economic recovery post-COVID. The still-sluggish global smartphone and consumer electronics markets, coupled with continuing chip shortages, fractured supply chains, rising capital costs, and tighter credit markets make for a depressed sector. Only continued interest in AI offers a dim light at the end of the tunnel.
-
Sector Analysis
New![]()
Automotive ADAS and Autonomous Vehicles Market Trends and Analysis by Technology, Companies and Forecast to 2028
Automotive ADAS and Autonomous Vehicles Market Report Overview The ADAS and autonomous vehicles market size is estimated at 516.3 million units in 2023. The development of artificial chips and the adoption of legislation in various countries to facilitate autonomous vehicle development and deployment are driving the market’s growth. Furthermore, rising competition from industry outsiders and a geopolitical race to dominate the car industry with higher stakes are some of the key trends likely to aid the market in garnering a...
-
Sector Analysis
![]()
China Beverages Consumption Trends and Forecasts Tracker, Q2 2023
China Beverages Market Report Overview The China beverages market size was valued at 125.44 billion liters (BL) in Q2 2023. The Chinese economy grew in Q2 2023 mainly due to the rising tourist arrivals and declining inflation. The China beverages market research report covers key information about key beverages consumed in the country in Q2 2023. The report is an essential tool for keeping up to date with the latest beverage industry performance and developments every quarter. Buy the Full...
-
Thematic Analysis
![]()
Impact of China on Medical Devices Industry – Thematic Intelligence
Impact of China on Medical Devices Industry Report Overview China is among the top 10 largest medical device markets worldwide and is regarded as one of the most promising. The estimated market value of medical devices in China was $44.8 billion in 2023, accounting for around 8% of the world total. China’s medical devices market is forecast to grow at a CAGR of more than 5% through 2025. The key market drivers include the country’s aging population, increasing chronic conditions,...
-
Sector Analysis
New![]()
China Destination Tourism Trends Insight by Type, Source Markets, Foreign Direct Investment and Future Opportunities, 2023 Update
China Destination Tourism Insight Report Overview The total number of international arrivals in China amounted to 3.7 million in 2022. Domestic travel dominates China's tourist income. Furthermore, the tremendous economic expansion over the last 40 years has encouraged the development of inbound tourism through quick and much-needed improvements in infrastructure. Tourism has undeniably emerged as a pivotal contributor to the Chinese economy, assuming a position as the nation's foremost service export. Infrastructure has played a very important role in tourism...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Trastuzumab Deruxtecan in Recurrent Glioblastoma Multiforme (GBM)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Trastuzumab Deruxtecan in Recurrent Glioblastoma Multiforme (GBM) Drug Details: Trastuzumab deruxtecan (Enhertu, Detrastuzumab) composed of...
-
Sector Analysis
![]()
China Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast, 2023-2027
China Construction Market Report Overview The China construction market size was $4.6 trillion in 2022. The market is projected to achieve an AAGR of more than 4% during 2024-2027. The growth of the construction market during the forecast period will be supported by investment in development programs and infrastructure projects. Further support for construction activity will be provided by works as part of the 14th Five-Year Plan (2021–2025). China Construction Market Outlook, 2022-2027 ($ Trillion) Buy Full Report to Know...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Lerodalcibep in Heterozygous familial hypercholesterolemia (heFH)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Lerodalcibep in Heterozygous familial hypercholesterolemia (heFH) Drug Details: Lerodalcibep is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Lerodalcibep in Homozygous Familial Hypercholesterolemia (HoFH)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Lerodalcibep in Homozygous Familial Hypercholesterolemia (HoFH) Drug Details: Lerodalcibep is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TPX-107 in Limbal Stem Cell Deficiency (LSCD)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TPX-107 in Limbal Stem Cell Deficiency (LSCD)Drug Details:TPX-107 is under development for the treatment of limbal...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BRII-732 in Human Immunodeficiency Virus (HIV) Infections (AIDS)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.BRII-732 in Human Immunodeficiency Virus (HIV) Infections (AIDS) Drug Details: G M T Y Detect languageAfrikaansAlbanianAmharicArabicArmenianAzerbaijaniBasqueBelarusianBengaliBosnianBulgarianCatalanCebuanoChichewaChinese...
-
Product Insights
![]()
Hanzhong Park Inv – Hanzhong Chinese and foreign Modern Chinese Medicine Industrial Park – Shaanxi
Equip yourself with the essential tools needed to make informed and profitable decisions with our Hanzhong Park Inv - Hanzhong Chinese and foreign Modern Chinese Medicine Industrial Park - Shaanxi report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash...
-
Product Insights
![]()
Chinese Univ HK – The Chinese University of Hong Kong Affiliated Shenzhen Jihua Hospital – Guangdong
Equip yourself with the essential tools needed to make informed and profitable decisions with our Chinese Univ HK - The Chinese University of Hong Kong Affiliated Shenzhen Jihua Hospital - Guangdong report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report?...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – PRTX-007 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRTX-007 in Solid Tumor Drug Details: PRTX-007 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Arbaclofen Er in Opium (Opioid) Addiction
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Arbaclofen ER in Opium (Opioid) Addiction Drug Details: Arbaclofen (OS-440) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CBP-501 in Solid Tumor
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.CBP-501 in Solid Tumor Drug Details:CBP-501 is under development for the treatment of solid tumor, non-small...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CBP-501 in Pancreatic Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. CBP-501 in Pancreatic Cancer Drug Details: CBP-501 is under development for the treatment of solid...
-
Product Insights
New![]()
Orthopedic Bone Cement and Casting Materials Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Bone cement and casting materials are used to fix bone fractures or as a complement to other devices in procedures such as joint reconstruction and trauma fixation. GlobalData's Medical Devices sector report, “Orthopedic Bone Cement and Casting Materials Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Orthopedic Bone Cement and Casting Materials pipeline products with comparative analysis of the products at various stages of development and...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Trastuzumab Deruxtecan in Metastatic Colorectal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Trastuzumab Deruxtecan in Metastatic Colorectal Cancer Drug Details: Trastuzumab deruxtecan (Enhertu, Detrastuzumab) composed of a...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.